https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-il-business-europeo-orladeyo-da-biocryst-pharmaceuticals/2025-11-21T16:26:04+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-al-fianco-dei-bambini-con-disabilita-per-vivere-un-pomeriggio-di-musica-inclusione-e-condivisione/2025-07-10T14:04:38+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/fab13-le-aziende-storiche-del-made-in-italy-farmaceutico-si-confermano-motore-delleconomia-nazionale/2025-07-10T14:05:08+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-s-p-a-colloca-un-ammontare-di-e100-milioni-di-senior-secured-notes/2025-11-13T09:33:13+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-i-prodotti-a-base-di-metoclopramide/2025-11-13T15:13:52+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/ragazzi-protagonisti-del-pomeriggio-sportivo-al-palaluiss/2025-07-10T14:05:29+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/eric-falcand-e-il-nuovo-ceo-di-neopharmed-gentili/2025-07-10T14:05:47+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-s-p-a-annuncia-il-cambio-del-ceo/2025-07-10T13:01:17+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-s-p-a-colloca-bond-da-e750-milioni/2025-07-10T14:05:40+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/sport-e-disabilita-un-connubio-vincente/2025-07-10T14:05:54+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/disfunzione-erettile-maggiore-consapevolezza-del-problema/2025-07-10T14:06:00+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/ardian-rileva-la-maggioranza-di-neopharmed-gentili-societa-controllata-da-mediolanum-farmaceutici/2025-07-10T14:07:36+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-mdm/2025-07-10T14:07:25+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/appuntamento-con-il-business-tech-forum/2025-07-10T14:07:18+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/pressione-arteriosa-attenzione-a-non-trascurare-i-valori-borderline/2025-07-10T14:06:55+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/covid-19-lo-stress-da-pandemia-peggiora-il-dolore-cronico/2025-07-10T14:06:49+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/annual-report-social-2020-neopharmed-gentili/2025-11-24T15:08:29+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-i-prodotti-a-base-di-lormetazepam/2025-07-10T14:06:40+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-dona-farmaci-per-lucraina/2025-07-10T14:06:34+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-litaliana-valeas/2025-07-10T14:06:21+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/nb-renaissance-nuovo-socio-per-neopharmed-gentili-e-ardian/2025-07-10T14:06:15+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-dona-50000-euro-per-il-terremoto-in-turchia/2025-07-10T14:06:09+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/al-via-storie-in-ascolto/2025-07-10T14:06:28+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/un-impegno-responsabile-e-concreto-verso-le-persone-lambiente-e-la-comunita/2025-11-12T16:52:37+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-completa-lacquisizione-del-business-europeo-di-orladeyo-da-biocryst-pharmaceuticals/2025-10-20T12:05:36+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-sostiene-lo-sport-come-strumento-di-inclusione-e-liberta/2025-11-04T10:24:40+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/ipnosis-levento-di-neopharmed-gentili-sullinsonnia/2025-12-05T11:32:31+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-al-fianco-di-fondazione-libellula/2025-11-24T09:24:05+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/nuovo-accordo-di-licenza-con-lupin-limited-per-la-commercializzazione-e-la-promozione-di-plasil-in-brasile-e-nelle-filippine/2025-12-18T09:52:42+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/a-milano-levento-scientifico-di-neopharmed-gentili-gli-esperti-accendono-i-riflettori-sulla-salute-delle-gambe/2026-03-26T09:32:32+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/neopharmed-gentili-acquisisce-i-diritti-esclusivi-per-navenibart-in-europa-da-biocryst-pharmaceuticals/2026-05-05T09:04:03+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/haello-were-heare-its-not-what-it-seems-decode-the-rare/2026-06-05T09:43:45+00:00https://uat.neogen.segnoeforma.cloud/it/news-e-comunicati-stampa/il-chmp-esprime-parere-positivo-per-lestensione-pediatrica-di-orladeyo-berotralstat-nel-trattamento-dellangioedema-ereditario/2026-06-26T10:36:49+00:00